Macoin J, Lissilaa R, Sancheti P, Reddy V, Back J, Wolff G. Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses. J of Skin [Internet]. 2018 Dec. 17 [cited 2024 Jul. 3];2:S62. Available from: https://jofskin.org/33014/index.php/skin/article/view/458